AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
[ILLUSTRATION OMITTED]
A new drug called KAI9803 being developed at Duke Clinical Research Institute looks promising to reverse damage caused during a heart attack. In animal tests, the drug reduced damage to the heart muscle and restored pumping ability. Its first placebo-controlled safety trial in humans was a success, it was reported in Circulation's February issue. The drug was injected into the coronary arteries of 154 heart attack patients immediately ...